C07K 14/4718
Cytokine-induced proteins
Official title: {Cytokine-induced proteins}
C07K14/4718 (Cytokine-induced proteins) appears on 105 US grants and 116 published applications in this corpus.
Search patents in C07K- Granted patents
- 105
- Published applications
- 116
- Assignees
- 59
- Inventors
- 184
- Latest grant
- 12 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 7 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 1 |
| 2002 | 3 | 7 |
| 2003 | 4 | 16 |
| 2004 | 0 | 4 |
| 2005 | 5 | 6 |
| 2006 | 5 | 7 |
| 2007 | 3 | 5 |
| 2008 | 1 | 4 |
| 2009 | 4 | 4 |
| 2010 | 2 | 4 |
| 2011 | 1 | 3 |
| 2012 | 5 | 4 |
| 2013 | 7 | 6 |
| 2014 | 1 | 3 |
| 2015 | 4 | 2 |
| 2016 | 1 | 8 |
| 2017 | 6 | 9 |
| 2018 | 3 | 5 |
| 2019 | 5 | 4 |
| 2020 | 3 | 5 |
| 2021 | 2 | 2 |
| 2022 | 2 | 3 |
| 2023 | 5 | 0 |
| 2024 | 2 | 3 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Intracellular genomic transplant and methods of therapy12 Mar 2024US 11,925,664 B2Intima Bioscience, Inc.
- Intracellular genomic transplant and methods of therapy20 Feb 2024US 11,903,966 B2Intima Bioscience, Inc.
- Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)28 Nov 2023US 11,827,910 B2President and Fellows of Harvard College
- Intracellular genomic transplant and methods of therapy9 May 2023US 11,642,374 B2Intima Bioscience, Inc.
- Intracellular genomic transplant and methods of therapy9 May 2023US 11,642,375 B2Intima Bioscience, Inc.
- Use of link-tsg6 for the treatment of osteoarthritic pain17 Apr 2025US 2025/0121028 A1The University of Manchester
- Methods of engineering immune cells for enhanced potency and persistence and uses of engineered cells in immunotherapy10 Oct 2024US 2024/0335536 A1Nkarta, Inc.
- Delivery of cas9 via arrdc1-mediated microvesicles (armms)3 Oct 2024US 2024/0327478 A1President and Fellows of Harvard College
- Method for producing mesenchymal stem cells6 Jun 2024US 2024/0182862 A1Ajinomoto Co., Inc.
- Intracellular genomic transplant and methods of therapy17 Nov 2022US 2022/0362297 A1Intima Bioscience, Inc.
Most cited
By later US patents
- Purified amniotic membrane compositions and methods of use97US 8,153,162 B2Tissuetech, Inc. · 2012
- Amniotic membrane preparations and purified compositions and anti-inflammation methods67US 8,182,841 B2Tissue Tech, Inc. · 2012
- Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition65US 8,182,840 B2Tissue Tech, Inc. · 2012
- Intracellular genomic transplant and methods of therapy45US 10,166,255 B2Intima Bioscience, Inc. · 2019
- Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition42US 8,440,235 B2Tissuetech, Inc. · 2013